Ultragenyx Pharmaceutical | RARE - Attività Correnti

Prezzo Delle Azioni
19.87
Cambio Giornaliero
-0.55 -2.69%
Mensile
-11.73%
Annuale
-49.29%
Q1 Previsione
19.27




Attività Correnti Cambiamento Data
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 942.05M 91.06M 2025-12
Alnylam Pharmaceuticals USD 4.05B 97.85M 2025-12
BioCryst Pharmaceuticals USD 404.35M 48.66M 2025-12
BioMarin Pharmaceutical USD 3.95B 98.95M 2025-12
Esperion Therapeutics USD 462.57M 102.11M 2025-12
Immunic USD 39.27M 20.57M 2025-09
Insmed USD 1.79B 137.6M 2025-12
Ionis Pharmaceuticals USD 2.99B 471.01M 2025-12
Karyopharm Therapeutics USD 89.75M 8.12M 2025-09
Kyowa Hakko Kirin JPY 493.35B 2.55B 2025-12
MacroGenics USD 219.94M 12.15M 2025-12
Moderna USD 6.54B 54M 2025-12
Neurocrine Biosciences USD 2.52B 364.3M 2025-12
PTC Therapeutics USD 2.27B 266.14M 2025-12
Puma Biotechnology USD 143.58M 7M 2025-09
Regeneron Pharmaceuticals USD 18.02B 41.2M 2025-12
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Ultragenyx Pharmaceutical USD 643.21M 76.58M 2025-09
Vertex Pharmaceuticals USD 11.2B 631.4M 2025-12
Xoma USD 110.71M 5.78M 2025-09